13024_2015_8_Article 1..15

First Page		Document Content
Immunology Health Vaccination Glycoproteins Biotechnology Immunization Monoclonal antibodies Antibody Alpha-synuclein Anatomy Biology Immune system		13024_2015_8_Article 1..15 Add to Reading List Source URL: www.molecularneurodegeneration.com Download Document from Source Website File Size: 2,35 MB Share Document on Facebook

	Calcineurin determines toxic versus beneficial responses to α-synuclein Gabriela Caraveoa,b, Pavan K. Aulucka,c,1, Luke Whitesella, Chee Yeun Chunga, Valeriya Barua,b, Eugene V. Mosharovd, Xiaohui Yane, Manu Ben-Johnyf, DocID: 1qF8w - View Document
	News Release Ramot at Tel Aviv University Ltd. Announces Licensing Agreement with Dexcel Pharma Technologies Ltd. Under the agreement, a new therapeutic strategy for Parkinson’s disease will be developed using a natur DocID: 1qm73 - View Document
	Aggregated α-synuclein intoxication of primary dopaminergic neurons as an in vitro model of Parkinson diseaseD. Buttigieg ; E. Gras-Lavigne ; M. Ouamer ; R. Steinschneider DocID: 1oxVM - View Document
	Research Award Talene Yacoubian, MD, PhD. University of Alabama at Birmingham Project Title: Effects of 14-3-3s on Alpha-synuclein Release and Toxicity DocID: 1mVfo - View Document
	RAPID COMMUNICATION Neuron-to-Neuron Transmission of a-Synuclein Fibrils Through Axonal Transport Eric C. Freundt, PhD,1* Nate Maynard, PhD,2 Eileen K. Clancy, PhD,1 DocID: 1kFMY - View Document